sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks Mgcd-265

Mgcd-265

CAS No.:
875337-44-3
Catalog Number:
AG003AKW
Molecular Formula:
C26H20FN5O2S2
Molecular Weight:
517.5977
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$105
- +
2mg
98%
1 week
United States
$190
- +
5mg
98%
1 week
United States
$257
- +
10mg
98%
1 week
United States
$407
- +
50mg
98%
1 week
United States
$1140
- +
Product Description
Catalog Number:
AG003AKW
Chemical Name:
Mgcd-265
CAS Number:
875337-44-3
Molecular Formula:
C26H20FN5O2S2
Molecular Weight:
517.5977
MDL Number:
MFCD17779287
IUPAC Name:
N-[[3-fluoro-4-[2-(1-methylimidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-phenylacetamide
InChI:
InChI=1S/C26H20FN5O2S2/c1-32-14-20(29-15-32)23-13-19-25(36-23)22(9-10-28-19)34-21-8-7-17(12-18(21)27)30-26(35)31-24(33)11-16-5-3-2-4-6-16/h2-10,12-15H,11H2,1H3,(H2,30,31,33,35)
InChI Key:
UFICVEHDQUKCEA-UHFFFAOYSA-N
SMILES:
S=C(NC(=O)Cc1ccccc1)Nc1ccc(c(c1)F)Oc1ccnc2c1sc(c2)c1ncn(c1)C
UNII:
93M6577H9D
Properties
Complexity:
773  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
517.104g/mol
Formal Charge:
0
Heavy Atom Count:
36  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
517.597g/mol
Monoisotopic Mass:
517.104g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
141A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.9  
Literature
Title Journal
N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors. Bioorganic & medicinal chemistry letters 20091201
N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors. Bioorganic & medicinal chemistry letters 20090301
Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases. Bioorganic & medicinal chemistry letters 20080501
Properties